Risk factors for high-dose methotrexate-induced nephrotoxicity-Reference-Cited by-同舟云学术

Risk factors for high-dose methotrexate-induced nephrotoxicity

Published:2021-03-20 Issue:1 Volume:114 Page:79-84
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Kawaguchi Shinichiro,Fujiwara Shin-ichiro,Murahashi Rui,Nakashima Hirotomo,Matsuoka Sae,Ikeda Takashi,Toda Yumiko,Ito Shoko,Ban Tetsuaki,Nagayama Takashi,Umino Kento,Minakata Daisuke,Nakano Hirofumi,Yamasaki Ryoko,Ashizawa Masahiro,Yamamoto Chihiro,Hatano Kaoru,Sato Kazuya,Oh Iekuni,Ohmine Ken,Kanda Yoshinobu^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-021-03132-8.pdf

Reference20 articles.

1. Deborah AT, Stefan F, Susan O, Carlos BR, Jorge C, Guillermo GM, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569–80.

2. Sand TE, Jacobsen S. Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol. 1981;19:453–6.

3. Skarby T, Jonsson P, Hjorth L, Behrentz M, Bjork O, Forestier E, et al. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL). Cancer Chemother Pharmacol. 2003;51:311–20.

4. Jori M, Kenneth RC, Sara B, Weijian L, Nancy LB, Nina DWJ. High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis. Leuk Lymphoma. 2014;55:1345–9.

5. Jacobs SA, Stoller RG, Chabner B, David GJ. 7- hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. J Clin Invest. 1976;57:534–8.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;Cancer Chemotherapy and Pharmacology;2024-06-21

2. Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-01

3. Risk factors associated with high-dose methotrexate induced toxicities;Expert Opinion on Drug Metabolism & Toxicology;2024-03-19

4. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;2024-02-28

5. Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies;Chemico-Biological Interactions;2024-01